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ABSTRACT
Therapeutic doses of ionizing radiation result in changes in the structure and function of
microvascular networks in normal tissue. Previously, we reported on the early effects of ionizing
radiation on microvascular networks at 3, 7, and 30 days post-irradiation [1-3]. Data from the
early time points suggested that ionizing radiation significantly alters the structure and function
of microvascular networks and interferes with the normal processes of vessel maturation. Here,
we present our findings on the late effects of ionizing radiation on normal tissue
microvasculature at 60, 120, and 180 days post-irradiation. The cremaster muscle of Golden
Syrian hamster was locally irradiated (single 10Gy dose, delivered at 2 Gy/min). Microvascular
networks were selected in reference to a well-defined location in the tissue to reduce
heterogeneity due to spatial variation. Intravital microscopy was used to measure both structural
and functional parameters. Geographic Information Systems (GIS) technology was used to
establish network topology. At all late time points, the diameter of irradiated vessels was
significantly larger than control. Red blood cell velocity in irradiated vessels showed a significant
decrease from controls at 120 days post-irradiation and an increase at 180 days post-irradiation.
Others parameters such as lineal density, tortuosity, vessel length, and vessel tone showed no
significant difference between control and irradiated vessels. The hamster cremaster muscle
proved to be an effective model in examining the effects of radiation on normal microvascular
tissue. Together our early effect and late effect studies suggest that significant changes occur in
structural and functional parameters of irradiated microvascular networks and, hence, that
radiation therapy may alter the oxygen delivery capacity of normal tissue microvascular
networks.
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Chapter 1. INTRODUCTION
Cancer is the second leading cause of death in the United States and in many other
industrialized countries. However, this dreaded disease, which was synonymous with death, has
yielded to the advances in modern treatments that include surgery, radiation therapy, and
chemotherapy. Cancer cells can arise in any body tissue, at any age. Characteristically, they
invade local tissues by direct extensions, or they spread throughout the body through lymphatic
or vascular channels. As infectious diseases are brought under control and increased longevity
results, the incidence of cancer in a given population will certainly rise. In this country, one in
every four Americans will be diagnosed with cancer, and approximately 50% to 60% of those
diagnosed as cancer patients will probably die from their disease [9].
The exact cause of cancer remains undetermined. Although there are readily recognizable
histopathologic differences between the cancer cell and the normal cell, few metabolic
differences have been determined. The biochemical structure of nucleic acids is similar in both
types of cells, but some reduction of vital proteins, such as respiratory enzymes, cytochromes,
and cytochrome oxidase exists in cancer cells [10]. Evidence suggests the conversion of normal
cellular genes (c-onc) responsible for cellular metabolism, division, and maturation, to malignant
oncogenes leading to uncontrolled growth [10]. More than one of these genes could be involved,
and a set of anti-oncogenes (anti-onc) was recently identified that function as cellular repressors.
This network of coordinated gene expression is ultimately responsible for the activation of
uncontrolled cell growth producing a malignancy [12].
Of the known carcinogenic agents- chemicals, viruses, and radiation- chemicals have
emerged as the most important in the induction of human cancers. Their common feature is that
they are electrophilic reactants, arising through metabolism [10]. Environmental and industrial
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carcinogens such as tobacco and alcohol have been linked to cause lung cancer and upper
aerodigestive tract malignancies. Radiation exposure is high on the list of carcinogens because
of its known destructive action. However, a small fraction-less than 1% - of all cancer is
attributable to this cause. Drug-induced cancers are also of particular concern to the oncologists
because a new tumor can arise after curing the first. For example, the use of alkylators for
treatment of cancer (e.g. melphalan and cyclophosphamide) is known to induce other leukemias
and bladder cancers [13]. In addition, the combination of multi-agent chemotherapy and
irradiation, used in treating a variety of cancers, has also resulted in secondary leukemias.
Finally, a few type DNA and RNA viruses have been shown to cause human malignancies. The
Epstein-Barr virus and hepatitis B virus are two agents that chronically infect humans and are
associated with neoplasms.
Almost by definition, both benign and malignant cells must proliferate in order to
produce a tumor (i.e., a mass). Tumor cell proliferation is autonomous, and thus, its control
mechanism must therefore be abnormal [14]. However, malignant cells may respond to normal
control signals (e.g., proliferation of breast cancer cells may be stimulated by low levels of
estrogen and inhibited by high levels). The growth of some tumor cells appears to depend upon
growth factors that the tumor cells themselves secrete, inappropriately. In normal proliferating
tissues such as the intestinal crypt cells, the cell cycle is generally 24-48 hours. Likewise,
malignant cells have similar cell cycle time. However, the abnormal growth of a tumor’s mass is
due to the persistence of cycling rather than a rapid rate of cycling. In normal proliferating
tissues, stem cells divide and daughter cells begin to differentiate. After a defined number of
divisions, the daughter cells differentiate to terminal cells and cannot divide again. In tumor
arising in stem cell systems, proliferation per se is not abnormal because the normal cell of origin
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proliferates. Instead, differentiation to form terminal cells is either abnormal and delayed or
absent in cells of the malignant clone [14]. In tumors arising from cells that are normally
nonproliferating, such as liver cells, the activation of proliferation is a recognized abnormality,
and proliferative signals are presumed to be altered.
As for tumor growth rate, when tumors are small, the number of cells in the tumor
increases exponentially and rapidly as would be predicted from the cell cycle time of 1-2 days.
However, as the tumor enlarges, the number of cells in the tumor ceases to grow exponentially
but instead grows progressively more slowly. More and more tumor cells cease to proliferate and
more and more tumor cells die. One reason for this is that as the mass grows, many cells become
distant from the blood vessels and therefore become nutrient-deprived; they stop proliferating
and often die (necrose). Most tumors have areas of necrosis. In addition, in many tumors, a
proportion of the cells appear to differentiate to terminal cells. This must be the case because if a
10 gram tumor doubled every 2 days, as an individual cell can, it would weigh over 1 kg in 2
weeks, and over 100 kg in another 2 weeks. Finally, it is also hypothesized that some cells
accumulate so much genetic damage that they die [14].
Benign tumor cells, which also can proliferate autonomously, can be distinguished from
malignant cells by the characteristic that malignant cells invade neighboring tissues or
metastasize to distant regions. Malignant tumor can invade into blood or lymph vessels and
metastasize to other parts of the body. The regulation of this program is not understood, but
invasiveness is a normal characteristic of macrophages, lymphocytes, granulocytes, fibroblasts in
wound, certain migrating embryonal cells, and placental cells, for instance.
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Cancer Treatments
Treating cancer is difficult because it is not a single disease and because all the cells in a
single tumor population do not behave in the same way [15]. Many believe that cancers are
derived from a single abnormal cell, but by the time a tumor is detected, most cancers contain
diverse populations of cells. Some of the cells may metastasize and others do not. Some may
divide and others may not. Because of this diversity, a single chemotherapeutic drug may destroy
susceptible populations of cells but permit resistant populations to proliferate. This is a big
drawback of chemotherapy. Certain tumor cells may be simultaneously resistant to completely
unrelated drugs, a phenomem called multi-drug resistance [15]. This broad-based resistance to
chemotherapeutic drugs is due to a plasma membrane protein called P-glycoprotein (PGP) that
accumulates in resistant tumor cells. PGP actively transports drugs out, and the cells are not
killed [15]. Another obstacle encountered by blood-borne anticancer drugs is the physical barrier
posed by solid tumors such as those that arise in the breast, colon and other organs. Because of
their size, deep within such tumors are high-pressure areas that cause blood vessels to collapse
[16;17]. This makes it difficult, if not impossible, for blood-borne anticancer drugs to penetrate
the tumor. For these reasons, chemotherapy is often used in combination with others method of
treatment (e.g., radiation therapy, surgery, etc.).

Ionizing Radiation
Ionizing radiation from radium was discovered by Roentgen and Curie in the late 1890s.
Since then ionizing radiation has been used to treat a variety of diseases, particularly cancer.
Today, radiation therapy is the second most commonly used method of treatment for cancer after
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surgery. Of the 1.5 million diagnosed cancer cases per year in the U.S., around 400,000 patients
undergo some form of radiation therapy [18].
Ionizing radiation can be classified into two types: electromagnetic or particulate.
Electromagnetic radiation consists of x-rays and gamma rays. X-rays are produced in a machine
that accelerates electrons to high energy and then stops them using tungsten or copper. Part of
the stopping energy is dissipated as heat and the remainder is converted into x-rays. On the other
hand, gamma rays are emitted from the nucleus of radioactive isotopes through unstable nucleus
decay. Particulate radiation includes electrons, protons, neutrons, and alpha particles. Electrons
are negatively charged particles that can be accelerated in a variety of machines. Protons can also
be accelerated because they possess a positive charge. Neutrons are produced by colliding
protons or deuterium into appropriate targets. Alpha particles currently are of no particular
clinical importance.
X-rays and gamma rays are absorbed in tissue by a process called the Compton effect.
The process involves a photon interacting with an orbital electron, overcoming the electron
binding energy and imparting some kinetic energy that ejects the electron in one direction while
the energy-reduced photon scatters in a different direction (see Figure 1-1).
Figure 1-1. Compton effect. An
energetic photon interacts with an
orbital electron, overcoming the
electron binding and imparting
some kinetic energy that ejects the
electron in one direction while the
energy-reduced photon scatters in
a different direction. From
Hendrickson et al. [4].
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The recoil electron will interact with other electrons and gradually lose its kinetic energy. The
scattered photon may react further and give up more energy as it traverses the tissues. On the
other hand, protons and neutrons interact directly with the molecular nucleus, ejecting varying
lower-energy nuclear fragments. Because protons and neutrons are heavier particles, the energy
deposits are closer together than those produced by photons and electrons. This deposition is
called high linear energy transfer (LET) radiation and is different from the low–LET radiation of
photons and electrons. Conceptually, low-LET radiation is like skipping stones on water. A
light stone (photon or electron) thrown with moderate energy will touch the water and skip each
time with less distance until all the energy has been dissipated. High-LET radiations would be
heavier stones requiring greater energy behind the throw, but as it skips, it impart a great deal of
energy to the water but with much less distance between each skip [4].
Ionizing radiation can be delivered in two ways: teletherapy and brachytherapy. In
teletherapy, the source of the radiation is some distance from the patient. This long distance is
advantageous because it allows room for a uniform dosage to be delivered using modifying
devices (i.e., collimator) placed between the source and the patient. In brachytherapy, the
radioactive sources (e.g., radium) are placed directly into the tumor site. Because of the inverse
square law, the radiation dosage is high near the sources in the tumor and much lower in the
normal tissues further away from the radioactive sources. A combination of teletherapy and
brachtherapy is used in the treatment of many common tumors [4].
Optimal radiation therapy of malignant disease is achieved when the tumor is completely
eradicated and the surrounding normal tissues show little evidence of structural and functional
damage. Although this “ideal effect” is being obtained more frequently, one accepts a certain
degree of permanent residual damage as a sequel to the destruction of a lethal tumor [6]. This
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ability to eradicate the tumor without undue complication or destruction of normal tissues is the
essential factor in tumor radiocurability and is referred to as the therapeutic ratio [6]. The
relation between radiation dose and the probability of control of a homogeneous group of tumors
is sigmoidal; that is , with increasing radiation doses, more and more neoplastic cells are killed,
until ultimately all clonogenic cells are destroyed and a cure is achieved. The same principle of
radiation killing, however, also applies to normal cells and tissues, and so the probability of
normal tissue complications and tumor cure are similar. Because there are vast varieties of
human tumors and different normal organs and tissues, each with different cell types, the overlap
in the tolerance dose of normal tissues and the tumor dose for cure is inevitable. It is this relation
between normal tissue tolerance and tumor lethal dose that determines the therapeutic ratio (see
Figure 1-2) [5].

Figure 1-2. Therapeutic ratio. The response
curves of both tumor cure and normal tissue
complication are sigmoidal. The differential
in dose to achieve these effects is the
therapeutic ratio. From Wilson [5].
The therapeutic ratio is favorable when the tumor curve is to the left of the normal tissue
dose effect curve (Figure 1-3a). This means the tumor can be destroyed without excessive
normal tissue complication. When the two curves are identical (Figure 1-3b), the therapeutic
ratio is less favorable, but may be improved by precise radiation treatment, so that a greater dose
is delivered to the tumor than to the normal surrounding tissue [6]. Finally, if the tumor ablation
curve is to the right of the vital normal tissue (Figure 1-3c), the circumstance is most
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Figure 1-3. Different therapeutic ratios exist in different clinical
circumstances depending on the radiosensitivity (dose response curves) for
tumor versus the critical normal tissue in the treatment field. These figures
show (a) a favorable ratio, (b) a less favorable ratio, and (c) an unfavorable
ratio. From Rubin et al. [6].
unfavorable. To reverse this situation, innovations and combined modality approaches (e.g.,
radiation therapy with chemotherapy) are essential to a good outcome [6].
In describing the radiobiologic basis for radiation oncology, two concepts are often used.
They are the dose-response curve and the clonogenic cell survival fraction. The dose-response
curve (see Figure 1-4) is sigmoidal and characterizes the relationship between dose and a
response on effect, such as tumor control or normal tissue damage [6]. As the dose increases,
more cells are destroyed, and depending on the radiosensitivity of the tumor cells, a cumulative
dose can be achieved to completely eradicate the tumor.

Figure 1-4. A sigmoidal doseresponse curve characterizes the
relation between both tumor
control and normal tissue
damage versus dose. As the
radiation dose increases, a
threshold is reached beyond
which both tumor control and
normal tissue injury increase.
From Rubin et al. [6].
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The clonogenic cell survival graph (see Figure 1-5) represents the fraction or proportion
of cells surviving irradiation based on measurements made on cells in tissue culture. Following
an initial shoulder region, the radiation killing is essentially

Figure 1-5. A clonogenic cell survival curve
represents the fraction or proportion of cells
surviving irradiation. On a semilog plot, after
an initial shoulder, the curve bends downward
sharply and radiation killing become more
effective for each cGy absorbed. Cell survival
are described by their shoulder (Dq) and slope
(Do) parameters. From Hall [7].

logarithmic or exponential. These curves can be described by their shoulder (Dq) and their slope
(Do). The radiosensitivity is referred to by the Do where Do is required to reduce the survival to
37% along with the exponential portion of the curves. With this understanding, we can now look
into a very important concept of radiation therapy: dose-time relationship.
The magnitude of the radiation dose is not the only-important variable. Of equal
importance is the distribution of the dose with respect to time—the fractionation factor. Figure
1-6 shows an idealized fractionation experiment by Elkind and Whitmore using cultured cells in
vitro [8]. The survival curve for single acute exposure of x-rays is
Curve A. Curve S is obtained if the total dose is given as a series of small fractions of the size
D1, with the time interval between fractions sufficient for repair of sublethal damage
to take place. From this, it is evident that a much larger total dose of radiation is required to
achieve the same degree of killing when it is given in a series of small fractions as compared
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Figure 1-6. Cell repair and fractionation
effect. Each repeated fractional dose
allows for cell repair of sublethal damage
and is expressed by recapitulation of the
shoulder of the survival curve. If 1,000
cGy is given as a divided fractional dose
(D1, D2, D3, D4, D5) of 200 cGy daily, it
achieves a similar degree of cell kill (S) as
600 cGy given in one single exposure (A).
From Elkind et al.[8].

with a single large exposure. Finally, clinical experience has shown that normal tissues recover
more rapidly than neoplastic tissues. Therefore, by increasing the total dose over a longer period
of time, the differential between the tumor lethal dose and tissue tolerance dose can be lessened.
The prescribed dose for different human tumors is not a fixed dose, but varies with tumor
size and extent, tumor type, pathologic grade and differentiation, and its response to irradiation.
The tumor lethal dose may be defined as the dose that has a 95% probability of achieving tumor
control (cure) – TCD95. Highly radiocurable tumors such as seminomas, lymphosarcomas,
Hodgkin’s disease, and medulloblastomas are treated in a dose range 3.5 to 6 Gy (TCD95) [6].
Radiocurable tumors (TCD95 range 6 to 7.5 Gy) are those requiring the risk of exceeding normal
tissue tolerance to assure a high degree of curability [6]. These are moderate to large tumors of
the oral cavity, pharynx, bladder, cervix, uterus, ovary, and lung. The least radiocurable tumors
(TCD95 range 8 Gy and above) are those large to massive squamous cell and adenocarcinomas
that are less consistently cured by irradiation alone and in which the 95% level is not reached [6].
Some of the recent breast cancer data confirm that tumor control of massive tumors is possible
with doses higher than 7 Gy, but such radiation doses are associated with a high incidence of late
normal tissue damage. Therefore, radiation oncologists and physicists must decide on an
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appropiate radiation dose that will minimize normal tissue damage but be effective enough to
eradicate the tumor.

Effects of Ionizing Radiation
Normal tissue responds to irradiation at two different levels: 1) acute effects that appear
within a short time and 2) late effects that appear months or even years after irradiation. The
higher the fractional and total dose and the shorter the time of exposure, the more rapid the onset
of tissue necrosis with many cellular compartments destroyed [19]. In this regard, there is always
a dose-limiting tissue in the radiation field, and in most cases, it is the vasculoconnective tissue
component [19]. Although direct parenchymal cellular depletion of an organ occurs after
irradiation, it is often the microvascular circulation that rapidly occludes and infarcts tissues
leading to necrosis [19]. This slows the transport of oxygen and vital metabolites and, in turn,
contributes to the parenchymal cell depletion, hypoplasia and an eventual late effect [19].
Studies have shown that endothelial cells and smooth muscle cells are gradually lost from the
wall of blood vessels after irradiation [20]. These findings also suggest that the amount of
depletion is dose-related and endothelial cell loss occurs earlier than that of smooth muscle cells.
In slowly repopulating or non-repopulating tissues, the production of parenchymal
hypoplasia is due both to direct cell effects and indirect effect of the microvascular tissue stroma.
In both circumstances, the slowly progressive arteriolar fibrosis and interstitial fibrosis after
irradiation contribute to the delayed parenchymal hypoplasia and cause the late effects of
radiation [19]. Furthermore, lesions occur in the endothelium of small vessels such as arterioles,
capillaries, and venules. The resulting lesions are a consequence of inherent radiosensitivity of
the relevant cells, smaller diameter of the vessels for a given tissue, or direct organ damage from
21

parenchymal cell injury [19]. The swelling of endothelial cells leads to a narrowing obstruction
which impedes blood flow. This leads to thrombosis and regenerative attempts by the
endothelial cells. In another study, radiation instantaneously increased the vascular permeability
of endothelial cells even at doses of 2 Gy [21]. However, when examined at 16 to 24 hours post
irradiation, increased permeability was found at and beyond 8 Gy [21]. At 30 days post
irradiation, injury was not apparent up to 15 Gy. Thus there appeared to be an instantaneous
injury at the capillary level due to irradiation, which appeared to be dose related. Finally,
numerous investigations have substantiated one consistent change after irradiation of tissues: the
appearance of irregularly spaced vascular constrictions, particularly in the walls of arterioles
[19]. The possible development of such constrictions, because of slow depopulation of damaged
endothelial cells and reactive hyperplasia to regenerate the loss, can lead to clones of cells at
irregularly spaced intervals along the vessel wall, producing a “sausage segment” effect [22].
Radiation has increases leukocyte rolling and adhesion in normal tissue [23]. This
suggests that radiation might induce the release of inflammatory mediators to promote leukocyte
rolling and adhesion. However, in adenocarcinoma-bearing tissue, radiation did not cause the
same changes suggesting that radiation caused changes in the vascular surface properties such
that they become less adhesive to leukocytes [23].

Microvascular Networks
Individual microvascular networks are the basic functional building blocks of the human
vascular system [24]. Microvascular networks are defined as a series of interconnected
arterioles, capillaries, and venules with low Reynolds number flow and large surface area
providing a good environment for the supply of oxygen, nutrients, and the removal of waste
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products. Microvascular networks are the most sensitive part of the vasculature to ionizing
radiation. The interaction of blood cells (i.e., RBC, WBC, platelets, etc.) within endothelial cells
is significant to the function of normal tissue as well as the treatment of disease. Therefore, a
good indication of the health of tissue is the health of the surrounding microvasculature.
Understanding the mechanisms and the degree by which ionizing radiation damages the
microvasculature has important clinical ramifications.
Arterioles can range from 10 to 125 µm in diameter and have a multiple-layered
membrane. On the other hand, capillaries have diameters ranging from 7 to 20 µm and consist of
a single layer of endothelial cells. Venules are small veins with diameters ranging from 20 to
100 µm in diameter, with a wall of smooth muscle cells [1]. Arterioles have been shown to
regulate the microvascular network blood flow. Blood is supplied by arterioles and traverses
through multiple pathways of capillaries before draining into venules. The velocity of blood
within the microvasculature can vary between 100 to 2000 µm/s depending on the type of vessel
[25].
Microvascular blood flow is unique because of two phenomena called the Fahraeus and
Fahraeus-Lindqvist effects. The Fahraeus effect occurs in small vessels (d< 300=µm) due to a
decrease in the velocity of blood plasma relative to the red blood cell’s velocity [1;26]. For this
reason, the hematocrit inside the vessel is less than the systemic hematocrit. The FahraeusLindqvist effect states that a decrease in the effective viscosity of blood in small vessels due to a
decrease in vessel hematocrit results from a decrease in vessel diameter [27]. Therefore, when
analyzing hemodynamic parameters one must consider these phenomena to have reliable results.
The interconnectedness of the microvasculature is vital to its function, allowing blood
cells to migrate throughout the tissue. Studying complete microvascular networks provides
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information that can not be obtained from analyzing randomly selected vessels. The high degree
of interconnectivity and intravascular communication, coordination, and feedback exhibited in
microvascular networks requires an integrated approach to microvascular studies. In this project
the late effects of ionizing radiation on the structure and function of microvasculature networks
in the cremaster muscle of hamsters will be examined. By comparing structural and functional
data from the microvascular networks in irradiated and control tissue, we are able to assess the
microvascular damage caused by ionizing radiation.
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Chapter 2. OBJECTIVE
In the clinical arena, radiation oncologists and physicists try to find the best therapeutic
dosage of radiation for cancer patients. Too high of a dose will damage the normal tissue while
too low of a dose will not eradicate the tumor. In any case, direct exposure to ionizing radiation
leads to normal tissue damage. The extent of this normal tissue damage is the focus of our study.

Specific Aims
The main objective of this research was to quantify the late effects of ionizing radiation
(60, 120, and 180 days post-irradiation) on the structure and function of microvascular networks
in normal tissue. This study complements a previous study on the early effects of irradiation (3,
7, and 30 days post-irradiation) which was performed to obtain greater insight into the radiation
damage incurred by normal tissue [1-3]. A second objective was to determine whether the
methods, protocols, and procedures used in our early effects study would also be useful in this
late effects study.

Hypothesis
Therapeutic doses of ionizing radiation significantly alter the structure and function of
microvascular networks in normal tissue at late time points. This hypothesis assumes that
microvascular networks are the functional unit of the vascular system and that normal tissue
damage is a major dose limiting factor.
Secondly, the protocols used in the early effects study will provide an effective method to
examine the late effects of ionizing radiation on normal tissue.
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Key Questions
1. To what extent are structural (e.g., vessel diameter and length) and functional (e.g.,
RBC velocity and vessel wall shear stress) parameters of microvascular networks influenced
by ionizing radiation?
2. Do changes in structural and functional parameters of microvascular networks found in the
late effects study differ from the changes observed in the early effects study?
3. Does the extent of change in structural and functional parameters of irradiated networks vary
from vessel to vessel (i.e., arterioles, capillaries, venules)?
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Chapter 3. MATERIALS AND METHODS
Many aspects of the techniques, procedures, and experimental apparatus described in this
section have been described in detail elsewhere [1-3]. The methods described herein were used
to quantitatively study the late effects of ionizing radiation on the structure and function of
normal tissue microvascular networks at 60, 120, and 180 days post-irradiation. These methods
were used in a previous study which examined the early effects of ionizing radiation at 3, 7, and
30 days post-irradiation [1-3]. Therefore, only a summary of the materials and methods will be
discussed here.

Experimental Design
A hamster cremaster muscle model was used to examine the effects of ionizing radiation
on microvascular networks in normal tissue. The cremaster muscle is thin and transparent with
only two layers of vasculature which facilitates the use of intravital microscopy techniques. The
hamsters were 52 days of age (adolescent) and weighed approximately 85 grams at the time of
irradiation, which allowed for long term observations (i.e., 180 days) post-irradiation. Agematched control animals were used to account for changes in the microvasculature due to aging.
The hamster cremaster muscle was locally irradiated with a single 10 Gy dose. The
cremaster muscle was observed 60, 120, and 180 days post-irradiation. These time points are
representative of the late responses of microvascular networks in normal tissue due to radiation
exposure. Microvascular networks composed of precapillary arterioles, capillary, and postcapillary venules were observed. Networks were chosen in reference to a well-defined location
in the tissue to reduce heterogeneity due to spatial variations. Vessels within the network were
given a topological classification of type 1 (precapillary arteriole), type 2 (capillary), and type 3
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vessels (post capillary venule) based on the their two bifurcation ends. Type 1 vessels have both
diverging bifurcation ends while type 2 vessels have one diverging and one converging
bifurcation. Type 3 vessels consist of two converging bifurcations. The experimental design is
shown graphically in Figure 3-1.
Type 1
60 Days
Post-Irradiation

Type 2
Type 3
Type 1

Locally Irradiated
10 Gy Single Dose

120 Days
Post-Irradiation

Type 2
Type 3
Type 1

180 Days
Post-Irradiation

Type 2
Type 3

Cremaster Muscle
( Male Syrian) 52 days

Type 1
60 Days
Age Matched

Type 2
Type 3
Type 1

Control
Non-Irradiated

120 Days
Age Matched

Type 2
Type 3
Type 1

180 Days
Age Matched

Type 2
Type 3

Figure 3-1. Experimental design used to study the late effects of ionizing
radiation exposure of normal tissue microvascular. Adapted from Roth [1].

Irradiation
While the animal was anesthetized (25 mg/kg of Pentobarbital Sodium solution), a single
local 10 Gy dose was delivered to the testicles at a rate of 2 Gy/min using a Siemens MD-2 linear
accelerator (6 mV X-rays). Dose calculations and calibrations were performed by Dr. Sujit Ray
(Radiation Physicist at the Regional Medical Center, Memphis, TN) and Dr. Marc Sontag
(Radiation Physicist at St. Jude Children’s Research Hospital, Memphis, TN). After irradiation,
animals were returned back to their cages.
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Surgical Methods
The surgical methods described were a modification of a cremaster muscle preparation as
described by Baez (4). Prior to surgery, animals were anesthetized with an intraperitoneal
injection consisting of a mixture of 0.6 g/kg urethane and 0.09 g/kg α-chloralose. During
surgery, each animal’s body temperature was maintained at approximately 37oC. While the
animal was intubated, an intravenous catheter was inserted in the left femoral vein and used to
administer anesthesia and fluorescently labeled RBCs. The animal was placed on a surgical
board where the right cremaster muscle was pinned flat with minimal disruption. To simulate
physiological conditions, the exposed tissues were superfused at a rate of 5 ml/min with
bicarbonate buffered salt solution equilibrated with 5% CO2-95%N2 and maintained at 35±0.5oC.

RBC Fluorescent Labeling
Whole blood was taken by cardiac puncture from age-matched donor animals and was
washed and centrifuged three times with a hepes buffer solution to separate the RBCs and
remove the buffy coat and white blood cells. Packed RBCs were diluted in 10 ml Hepes buffer
solution with albumin and mixed with 0.1 ml of DiI fluorescent dye. The solution was gently
stirred using a 1 cm micro magnetic stirrer for one hour and then washed and centrifuged three
more times to remove excess fluorescent dye. Fluorescently labeled RBCs were delivered to the
experimental animals via a left femoral vein catheter.
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Identification of Microvascular Networks
Once the muscle was pinned, the tissue preparation was allowed to stabilized for 30
minutes before taking data. This allows sufficient time for the tissue to recovery from any
stresses incurred during surgery. During this time 0.1 ml of fluorescently labeled RBCs were
slowly injected using a standard 1 cc syringe via the femoral vein catheter. In the mean time, a
syringe pump was used to infuse a constant supply of anesthesia (36 % anesthesia and 64%
isotonic saline, delivered at 0.56 ml/hr) throughout the remainder of the experiment.
A few drops of a 10-4 M adenosine solution were applied topically to the preparation to
test for the presence of vascular tone in the second order arteriole supplying the network. A
vasodilation of at least 15% was required for the continuation of the experiment. Complete
microvascular networks were chosen in reference to a well-defined location (distal end of second
major arcade arteriole to bifurcate from the central feed arteriole) in the tissue to reduce
heterogeneity due to spatial variation [28].

Intravital Microscopy and S-VHS Recordings
Intravital microscopy techniques were used to observe microvascular networks. An
industrial grade microscope consisting of trans-illumination (Opti-Quip 75 Watt xenon light
source Model No. 1500, Highland Hills, NY) and epi-illumination (Nikon 150 Watt mercury
lamp Model No. HB-10101AAF, Japan) light sources was used. The microscope contained a
variety of neutral density filters which were used to adjust the light intensity at different
magnifications. In addition, a heat filter was incorporated in the light path reduce trauma to the
tissue. Two objective lenses (dry 10X and 20X water immersion) were used in conjunction with
the 10X eye pieces.
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Figure 3-2. Block diagram of video microscopy system. Arrows indicate
the signal pathway. Camera 1 and 2 represent the Hamamatsu CCD and
MTI CCD72 cameras, respectively. From Roth [1].
The primary camera assembly consisted of a CCD camera (MTI CCD Model No. CCD72,
Michigan City, IN) with an intensifier (MTI GenIISys Model No. 104722-01, Michigan City, IN)
(see figure 3-2). RBC velocity was measured using the 20X water immersion lens. A frame
integrator was also incorporated into the camera assembly which illuminated all the vessel paths
in the frame of view. On average 40 frames were required to get a sharp image of the illuminated
vessels. The images were later used to create a collage of images which represented the entire
microvascular network.
The secondary camera assembly consisted of a chilled CCD camera and controller
(Hamamatsu Model No. C5985, Japan). This camera was used to obtain trans-illumination
images with a 20X immersion lens from which vessel diameter was measured.
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The muscle preparation was viewed live on the video monitor and recorded on S-VHS
videotapes for off-line analysis. A digital video mixer was used to switch between the camera
assemblies. A video title maker was used to place text stamp (date, experimental number,
radiation status, and objective lens) on each video field. A time counter was also used to place
an electronic time on the video field (see figure 3-2).

Microvascular Maps
Methods for mapping microvascular networks have been published [2]. The collage of
videotaped fluorescent images were digitized using a drawing board (Calcomp DrawBoard III)
and AutoCAD software (AutoCAD 14.0 Map Release 2.0) to form maps of the complete
microvascular networks. Using GIS (Geographic Information Systems) technology, AutoCAD
Map has the unique feature of being able to establish topological and spatial relationships
between all vessels in a digitized network. Using a topology query, AutoCAD Map exported
information on vessel identification numbers, upstream and downstream nodes, and vessel
lengths to an external text file. Microvascular network parameters (i.e., topology, diameter, RBC
velocity, etc.) for all vessels in a network were recorded in an external database.
Blood vessels within a microvascular network were separated into three vessel types: type
1, type2, and type 3 vessels. Type 1 vessels were defined as vessels with diverging bifurcations
at both their upstream and downstream ends. Type 2 vessels were defined as vessels with one
diverging and one converging bifurcation whereas type 3 vessels converged at both upstream and
downstream bifurcations. No trifurcations were observed.
In addition, a subroutine was written in AutoLisp programming language and run in
AutoCAD MAP to color code the vessels of the microvascular network drawing to a specific
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parameter. This allows better representation of the parameters through the use of color.
Furthermore, the subroutine also converts the thickness of the vessels to its corresponding
diameter by importing data into AutoCAD MAP from an external database (Microsoft Excel 97).
The details on how to run the subroutine and the text of the subroutine can be found in Appendix
A.

Data Collection
At the end of each experiment, whole blood was collected into capillary tubes by toe clip.
The capillary tubes were placed in a microcentrifuge to measure systemic hematocrit. In
addition, a drop of blood was placed in 15 ml of Hepes buffer with albumin to determine the
labeled RBC fraction by flow cytometry (Coulter Epics Profile II, Miami, FL).
Measurements of vessel diameter, RBC flux, and RBC velocity for all vessels within a
microvascular network were made using a video caliper system. Vessel diameters were analyzed
off-line from S-VHS videotapes using an interactive routine developed within the MetaMorph
environment. Vessel diameter was considered to be the distance between the outside borders of
endothelial cells comprising the vessel wall. To reduce the variability in the diameter of the
vessel, multiple measurements were made at 20 µm intervals along the vessel length. A simple
average was used to estimate the diameter of a vessel.
Using the MetaMoph system for image analysis, RBC velocity measurements were taken
from fluorescent images. First, an image was acquired, and a marker was placed at the tip of a
labeled RBC. The videotape was then advanced a set number of frames and a second image with
the original marker was acquired. A line is drawn from the original marker to the tip of traveled
RBC. The line represented the distance traveled by the RBC which was measured by
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MetaMorph and automatically logged in a database (Microsoft Excel). To account for the
statistical variability in RBC velocity, fifteen measurements were taken for each vessel, and a
simple average was calculated.
RBC flux was measured by counting the number of fluorescently labeled RBCs crossing
a section of vessel per unit time. Flux measurement was made possible by using a time stamp
placed on the images. The videotape was advanced a set amount of time while the number of
labeled RBCs was measured using a hand counter (Compass Counter, Taiwan). The labeled
RBC flux was divided by the labeled cell fraction (obtained by flow cytometry) to obtain a true
measure of RBC flux.

Calculated Parameters
Hemodynamic parameters that could not be measured directly were calculated using the
data collected above.
The tortuosity of a vessel was estimated as the straight length divided by the actual length
(distance between end nodes of a vessel) and was computed as
T = 1−

Straight _ Length
Actual _ Length

Equation 3-1

Vessel hematocrit was calculated using the following equation:

Ht =

4 f RBCVc
VRBCπd 2
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Equation 3-2

where Vc is the mean RBC corpuscular volume, VRBC is the mean velocity, fRBC is the mean flux,
and d is the mean diameter. The mean RBC corpuscular volume for a hamster is assumed to be
approximately 70µm3. This equation assumes a circular cross-section for all vessels whereas
lineal density is independent of that assumption. Lineal density is the number of cells per unit
length at an instant in time and estimated using the following equation:

LD =

f RBC
V RBC

Equation 3-3

Measurements of vessel hematocrit and lineal density varied differently and thus both were
reported.
Due to the size of the microvessels, a parametric equation based on the Fahraeus effect
was used to estimate discharge hematocrit. This equation which was used for rat blood describes
the change in discharge hematocrit (HD) relative to tube hematocrit (Ht) [29].
Ht
− 0.415d
− 0.011d
= H D + (1 − H D ) • (1 + 17
. e
− 0.6 e
)
HD

Equation 3-4

After scaling the diameter exponents with the cube root of mean RBC corpuscular volume for
hamster blood (Rat: 61 µm3, Hamster: 70 µm3) and solving for discharge hematocrit we obtained

− R ± R 2 + 4 H t (1 − R )
HD =
2(1 − R )

Equation 3-5

where,

R = 1 + 17
. e

−0.4762 d

− 0.6 e

−0.0126 d

Equation 3-6
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The equation for discharge hematocrit is sensitive to the assumptions of circular cross-section
and diameter measurements for each vessel.
The effective blood viscosity in vivo is a parameter that changes with flow conditions
(i.e., vessel diameter, hematocrit, etc.). A parametric equation taking into account the variations
of relative effective viscosity with discharge hematocrit and vessel diameter for rat blood was
developed by Pries et al [30],

η rel

= 1+ e
e

H D •α

−1

0.45•α

−1

−1.424 d

• (110 e

+ 3 − 3.45 e

− 0.035 d

)

Equation 3-7

where
4

α=

Equation 3-8

− 0.593•( d − 6.74 )

1+ e

Again, scaling the diameter exponents in Equation 3.7 and 3.8 for hamster blood, and
multiplying Equation 3.8 by the viscosity of plasma in hamster blood at 37oC we obtained,

ηeff

e
= 116
. ê1 +
ê e

H D •α

0.45•α

−1
−1

• (110 e

−1.63d

− 0.04 d

+ 3 − 3.45 e

)ú
ú

Equation 3-9

where

α=

4
1+ e

Equation 3-10

− 0.593•(1.15d − 6.74 )

To calculate vessel shear stress, an estimate of the average blood velocity (VBlood) was
determined using the following relationship which takes in consideration the Fahraeus effect:

VBlood =

VRBC H t
HD

Equation 3-11
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Vessel wall shear stress (τw) was calculated from the following equation,

τ W = η eγ

Equation 3-12

where the vessel wall shear rate γ is given by

γ =

8VBlood
d

Equation 3-13

Combining Equations 3.12 and 3.13, we obtain a measure of vessel wall shear stress,

τW =

VBlood ηe
125d

Equation 3-14

Vessel wall shear stress is most sensitive to the accuracy and precision of diameter measurements
and is dependent on previously calculated values (Equations 3.7 and 3.11). Average RBC transit
time is an important indicator of the oxygen delivery capacity of a microvascular network. The
RBC transit time program consists of four main procedures [1]. First, using network topology all
possible paths within a network were determined. Next, entrance probability and travel time
were calculated. Entrance probability (EP) is the probability of a RBC entering another vessel at
a bifurcation from an upstream parent vessel and was calculated as

EP =

Fd
Fp

Equation 3.15

where Fd is the flux of the daughter vessel and Fp is the flux at the parent vessel. To satisfy
conservation of mass of RBCs, the probability of a vessel which converged at its upstream end
was set equal to one. RBC travel time for a vessel was the length of the vessel divided by its
RBC velocity and was given by
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TR =

L

Equation 3.16

VRBC

Thirdly, the probability of taking a path was the product of the entrance probabilities (Equation
3.15),for all vessels within that path. On the other hand, the RBC travel time for a path was the
summation of the RBC travel time (Equation 3.16) for all vessels with that path. Lastly, the
average RBC transit time was estimated as the summation of the product of the paths probability
and RBC travel time for all paths within that network. Because microvascular networks differ in
both the number of vessels and their vascular density, RBC transit time was divided by vascular
density to normalize the data.

Statistical Analysis
A factorial design was used to examine the effects of three factors and their interactions
on microvascular network structure and function. The factors and their subdivisions were
radiation status (i.e., control and irradiated), time post-irradiation (i.e., 60, 120, and 180 days
post-irradiation), and network vessel type (i.e., type 1, type 2, and type 3). Using Statgraphics
Plus software (Manugistics, Inc., Rockville, MD), multi-factor analysis of variance (ANOVA)
was used to test the effects of these factors and interactions. A multiple comparison procedure
(Fisher’s least significant difference) was used to discriminate among the means. Differences
between the means (control vs. irradiated) were considered statistically significant if P<0.05.
The sample size used in this study was N=5 animals per time point per treatment. The
sample size was determined in the early effect study by Noah Roth [1] using a graph of power
analysis of variance as a function of a non-dimensional parameter.
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Chapter 4. RESULTS
Changes in the structural and functional parameters of microvascular networks were
examined using a hamster cremaster muscle model at 60, 120, and 180 post-irradiation. The
study complements earlier work performed in our laboratory which examined networks at 3, 7,
and 30 days post-irradiation [1-3]. In both studies, five animals were used for each time point
group per treatment group. From each animal, one complete microvascular network was
analyzed. On average, each network contained approximately 37 vessels of which 46% were
type 1 vessels, 35% were type 2, and 19% were type 3 vessels. The number of vessels per time
point ranged from 334 to 412, and the total number of vessels studied was 1,111.
Data were collected for the following parameters: weight, arteriolar tone, vessel diameter,
length, RBC velocity, and RBC flux. From the data collected, the following parameters were
calculated: tortuosity, transient time, shear stress, lineal density, vessel hematocrit, and the
product of vessel hematocrit and RBC velocity. The data are presented as Mean=±=SEM
(Standard Error of the Mean). Multifactor analysis of variance (ANOVA) was used to examine
the effects of three factors (irradiation, age, and vessel type) and their interactions on structural
and functional parameters. Differences were considered statistically significant if P<0.05.

Result Summary
Animals were irradiated at 52 days of age where they each weighed approximately 85
grams. However after 60 and 120 days, the weights of irradiated animals were significantly less
than that of controls (see figure 4-1). At 180 days post-irradiation, irradiated and control animals
weighed approximately the same.
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Figure 4-1. Animal weight at 60, 120, 180 days post-irradiation (N=5
animals per time point per treatment group). Data are presented as Mean ±
SEM (P<0.05).

Vascular tone was measured using an application of adenosine solution (10-4M) to a
second order arteriole supplying each microvascular network, but results show no significant
difference between irradiated and controls. In addition, no significant differences in RBC transit
time between irradiated and controls were observed. Similarly, the capillary surface area of
irradiated vessels was not significantly different from control vessels.

Structural Parameters
Before discussing the structural parameters, it is important to note that no morphological
changes or unusual microvascular formations (e.g., aneurysms) were observed in irradiated
animals. The diameter of irradiated vessels significantly greater than controls at 120 days post40

irradiation. Data also indicate that the diameter of type 3 irradiated vessels were significantly
greater than controls for all time post-irradiation (see figure 4-2).
Length of irradiated vessels at 180 days post-irradiation was the only group significantly
less than controls. Measurements of tortuosity and vascular density showed no difference
between irradiated and control groups.

Functional Parameters
While average RBC velocity decreased with age in control animals, the average RBC
velocity in irradiated vessels showed a significant decrease from controls at 120 days postirradiation and then an increase at 180 days post-irradiation (see figure 4-3).
The RBC flux in vessels in irradiated networks was significantly greater than control at
180 days post-irradiation. At 180 days post-irradiation, irradiated animals had higher RBC flux
in all vessel types. Although there were no significant differences in RBC flux at 60 and 120
days post-irradiation, the RBC flux in type 3 irradiated vessels was significantly greater than
controls at all time points (see tables 4-1,2,3).
The calculated hematocrit of vessels in irradiated networks was significantly different
from controls at 120 and 180 days post-irradiation (see figure 4-4). At 180 days post-irradiation,
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Figure 4-2. Vessel diameter (N=5 animals per treatment group per time point) of
type 1, 2, 3, and all vessels at 60, 120, and 180 days post-irradiation. Data are
presented Mean ± SEM. Significant differences are indicated by * (P < 0.05).
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Figure 4-3. RBC velocity at 60, 120, 180 days post-irradiation
(N=5 animals per time point per treatment group). Data are
presented Mean ± SEM (P<0.05).
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Figure 4-4. Vessel hematocrit at 60, 120, 180 days post-irradiation (N=5
animals per time point per treatment group). Data are presented Mean ±
SEM (P<0.05).
43

Control
Irradiated

60
55

Vessel Hematocrit (%RBC s)

50
45
40
35

*

*
*

30
25

*

*

20
15
10
5
0
All Ves. Type1 Type2 Type3

All Ves. Type1 Type2 Type3

All Ves. Type1 Type2 Type3

60 Days

120 Days

180 Days

Time Post-Irradiation

Figure 4-5. Vessel hematocrit (N=5 animals per treatment group per time point) of type 1, 2, 3, and all
vessels at 60, 120, and 180 days post-irradiation. Data are presented Mean ± SEM. Significant
differences are indicated by * (P < 0.05).
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Figure 4-6. The product of vessel hematocrit and RBC velocity (N=5 animals per treatment group per
time point) of type 1, 2, 3, and all vessels at 60, 120, and 180 days post-irradiation. Data are presented
Mean ± SEM. Significant differences are indicated by * (P < 0.05).
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Figure 4-7. Vessel wall shear stress (N=5 animals per treatment group per time point) of type 1, 2, 3,
and all vessels at 60, 120, and 180 days post-irradiation. Data are presented Mean ± SEM. Significant
differences are indicated by * (P < 0.05).
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vessel hematocrit was significantly smaller in type 1 and 3 irradiated vessel. At 120 days postirradiation, vessel hematocrit in type 3 irradiated vessel was significantly smaller than control
(see figure 4-5). Lineal density, which is the number of RBCs per unit length, was not
significantly different between control and irradiated vessels.
The product of RBC velocity and vessel hematocrit, which is an index of oxygen delivery
capacity, was significantly different in irradiated and control animals. At 60 and 120 days postirradiation, type 1 irradiated vessels were significantly smaller compared to controls. Meanwhile,
at 180 days post-irradiation, the product of RBC velocity and vessel hematocrit was significantly
larger in irradiated networks (see figure 4-6).
Calculated vessel wall shear stress in irradiated networks was also significantly different
from controls. At 60 and 120 days post-irradiation, type 1 irradiated vessels were significantly
smaller than controls. However, at 180 days post-irradiation, type 1 irradiated vessel were
significantly greater than control (see figure 4-7).
A summary of all the data collected is presented in the following tables. Table 4-1 is a
summary of all the data for each age group. Table 4-2, 4-3, and 4-4 are summaries of data for 60,
120, and 180 days post-irradiation, respectively, with subdivisions of type 1, 2, 3, and all vessels.
Table 4-5, 4-6, and 4-7 contain summaries of data for type 1, 2, and 3 vessels, respectively, with
subdivision of time post-irradiation. Highlighted regions represent statistically significant data.
Data are presented as Mean +-SEM.
In addition, animal weight, RBC velocity, and vessel hematocrit from our early effects
study has been incorporated into Figure B-1, B-2, and B-3 (appendix B) in order to get a better
representation of the both early and late effects of ionizing radiation.
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Table 4-1

The Interactions of Time Post-Irradiation and Radiation Status for All Data

ANIMAL:

60 DAYS POSTIRRADIATION
CONTROL
IRRADIATED

120 DAYS POSTIRRADIATION
CONTROL
IRRADIATED

180 DAYS POSTIRRADIATION
CONTROL
IRRADIATED

141.2±7.64

119.8±7.64

179.2±7.64

139.4±7.64

149.0±7.64

149.2±7.64

32.6±7.85

29.6±7.85

31.06±7.85

40.5±7.85

19.88±7.85

15.54±7.85

456317±70156

465588±70156

624896±70156

561623±70156

599709±70156

527201±70156

1.253±0.352

1.568±0.352

2.068±0.352

2.044±0.352

3.791±0.352

1.723±0.352

d (µm)

10.88±0.38

11.83±0.36

12.21±0.38

13.30±0.37

13.07±0.44

13.99±0.41

L (µm)

159.28±11.68

162.06±11.04

177.09±11.61

157.78±10.74

221.68±11.98

185.54±10.67

11.72±1.37

11.00±1.30

10.89±1.37

11.65±1.26

16.30±1.41

14.97±1.25

558.2±26.83

517.3±24.63

411.8±27.94

303.71±25.27

270.27±26.89

476.92±25.09

W (g)

NETWORK:

VTone (%)
SA

(µm2)

tRBC (s)
STRUCTURAL:

T (%)
FUNCTIONAL:

VRBC (µm/s)
fRBC (RBC/s)
Ht (%)

163.41±16.13

177.6±15.24

112.52±16.24

120.55±14.83

127.77±16.70

197.65±15.81

20.30±2.62

21.46±2.32

27.48±2.60

20.64±2.55

29.95±2.91

22.21±2.58

LD (RBC/µm)

0.328±0.052

0.378±0.047

0.502±0.054

0.490±0.049

0.508±0.052

0.429±0.049

VRBCHt(RBCµm/s)

138.1±11.48

108.8±10.01

81.56±11.44

58.06±11.28

63.88±12.86

111.2±11.30

τW (N/m2)

0.475±0.034
0.420±0.030
0.325±0.034
0.236±0.033
0.311±0.038
0.397±0.034
Significant Difference between CN and IR
Data are presented as Mean ± SEM, N= 5 animals, and n = 1110 vessels
P<0.01
P<0.05
No Significant Difference between CN and IR
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Table 4-2

The Interactions of Vessel Type and Radiation Status for 60 Days Post-Irradiation
ALL VESSELS
IRRADIATED
CONTROL

TYPE 1
CONTROL
IRRADIATED

TYPE 2
CONTROL
IRRADIATED

TYPE 3
CONTROL
IRRADIATED

STRUCTURAL:
d (µm)

10.88±0.38

11.83±0.36

10.77±0.55

10.72±0.54

9.327±0.54

9.102±0.58

12.54±0.84

15.66±0.73

L (µm)

159.3±10.9

162.1±10.3

126.5±16.1

116.3±16.4

226.3±15.8

262.2±16.8

125.0±23.6

107.6±20.0

11.72±1.32

11.00±1.25

11.07±1.97

9.44±2.00

11.76±1.93

14.33±2.05

12.32±2.88

9.24±2.44

558.2±29.70

517.28±27.3

770.9±44.8

638.8±42.9

432.4±40.8

404.9±44.4

471.1±65.3

508.2±53.7

163.4±17.1

177.6±16.2

243.8±25.4

168.1±25.8

77.56±24.8

51.84±26.4

168.9±37.0

312.9±31.4

20.3±1.42

21.5±1.26

19.5±2.05

18.0±1.93

17.7±1.88

18.3±2.02

23.7±3.23

28.0±2.52

LD (RBC/µm)

0.328±0.034

0.378±0.031

0.258±0.051

0.226±0.048

0.186±0.046

0.159±0.050

0.541±0.074

0.750±0.061

VRBCHt(RBCµm/s)

138.2±15.7

108.8±13.7

215.8±22.2

111.2±21.6

105.6±20.5

70.84±22.2

93.12±36.2

144.4±27.0

T (%)
FUNCTIONAL:
VRBC (µm/s)
fRBC (RBC/s)
Ht (%)

τW (N/m2)

0.475±0.031 0.420±0.028 0.648±0.045 0.473±0.042 0.363±0.041 0.343±0.045 0.416±0.071 0.444±0.055
Significant Difference between CN and IR
Data are presented as Mean ± SEM, N= 5 animals, and n = 334 vessels
P<0.01
P<0.05
No Significant Difference between CN and IR
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Table 4-3

The Interactions of Vessel Type and Radiation Status for 120 Days Post-Irradiation
ALL DATA
IRRADIATED
CONTROL

TYPE 1
CONTROL
IRRADIATED

TYPE 2
CONTROL
IRRADIATED

TYPE 3
CONTROL
IRRADIATED

STRUCTURAL:
d (µm)

12.21±0.38

13.30±0.37

10.61±0.49

11.90±0.43

10.58±0.54

10.15±0.65

15.43±0.86

17.85±0.79

L (µm)

177.1±11.3

157.8±10.4

150.5±14.76

164.8±12.30

238.2±15.31

199.4±17.98

142.5±26.35

109.1±22.5

10.8±1.34

11.6±1.24

9.9±1.75

12.2±1.46

17.4±1.82

14.5±2.13

5.36±3.13

8.15±2.67

411.8±29.05

303.7±26.28

660.8±36.13

418.5±30.65

305.5±39.9

255.5±43.79

269.1±68.55

237.2±57.94

112.5±14.1

120.5±12.9

186.2±18.2

144.6±15.2

49.09±19.0

43.79±22.2

102.3±33.2

173.2±27.8

27.5±3.59

20.6±3.52

22.2±4.50

17.1±4.07

14.3±5.26

16.2±5.98

45.9±8.24

28.5±7.68

LD (RBC/µm)

0.502±0.075

0.490±0.068

0.286±0.093

0.250±0.079

0.186±0.103

0.176±0.113

1.034±0.177

1.044±0.149

VRBCHt(RBCµm/s)

81.56±8.26

58.05±8.14

145.5±10.34

78.72±9.42

58.81±11.94

41.56±13.83

40.34±19.08

53.88±17.78

0.325±0.032 0.236±0.031 0.603±0.040
Significant Difference between CN and IR
P<0.01
P<0.05

0.309±0.036

0.212±0.048

0.192±0.054

0.160±0.074

0.206±0.069

T (%)
FUNCTIONAL:
VRBC (µm/s)
fRBC (RBC/s)
Ht (%)

τW (N/m2)

Data are presented as Mean ± SEM, N= 5 animals, and n = 339 vessels
No Significant Difference between CN and IR
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Table 4-4

The Interactions of Vessel Type and Radiation Status for 180 Days Post-Irradiation
ALL DATA
IRRADIATED
CONTROL

TYPE 1
CONTROL
IRRADIATED

TYPE 2
CONTROL
IRRADIATED

TYPE 3
CONTROL
IRRADIATED

STRUCTURAL:
d (µm)

13.07±0.46

13.99±0.42

13.07±0.53

13.29±0.59

10.92±0.68

11.10±0.69

15.21±1.08

17.58±0.90

L (µm)

221.6±13.02

185.5±11.59

177.7±16.41

146.8±16.71

284.5±20.46

262.4±18.17

202.7±28.93

147.3±24.52

16.30±1.49

14.97±1.32

8.50±1.88

12.97±1.91

19.35±2.34

19.31±2.08

21.05±3.31

12.62±2.80

270.2±22.43

476.9±20.92

337.2±29.82

579.2±29.39

232.2±33.46

426.8±32.57

241.3±50.19

424.6±44.89

127.7±18.09

197.6±17.12

214.0±22.59

275.4±23.85

48.34±28.15

77.05±27.66

120.9±40.54

240.5±36.13

29.9±2.55

22.2±2.22

35.9±2.97

28.9±3.16

21.2±3.51

18.2±3.51

32.7±5.95

19.5±4.70

LD (RBC/µm)

0.508±0.039

0.429±0.036

0.631±0.052

0.477±0.051

0.285±0.058

0.207±0.057

0.607±0.088

0.603±0.078

VRBCHt(RBCµm/s)

63.88±9.51

111.2±8.35

101.4±11.28

190.0±11.67

40.56±13.32

73.58±13.17

49.66±22.56

69.92±17.84

0.310±0.043 0.397±0.038 0.417±0.052
Significant Difference between CN and IR
P<0.01
P<0.05

0.672±0.055

0.204±0.061

0.29±0.061

0.31±0.104

0.23±0.082

T (%)
FUNCTIONAL:
VRBC (µm/s)
fRBC (RBC/s)
Ht (%)

τW (N/m2)

Data are presented as Mean ± SEM, N= 5 animals, and n = 365 vessels
No Significant Difference between CN and IR
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Table 4-5

The Interactions of Time Post-Irradiation and Radiation Status for Type 1 Vessels
ALL DATA
IRRADIATED
CONTROL

60 DAYS
CONTROL
IRRADIATED

120 DAYS
CONTROL
IRRADIATED

180 DAYS
CONTROL
IRRADIATED

STRUCTURAL:
d (µm)

11.48±0.22

11.97±0.22

10.77±0.40

10.71±0.40

10.61±0.36

11.90±0.32

13.07±0.37

13.29±0.41

L (µm)

151.6±8.74

142.6±8.42

126.5±16.49

116.3±16.75

150.5±14.45

164.7±12.03

177.7±14.36

146.8±14.62

9.83±1.01

11.55±0.97

11.07±1.90

9.43±1.93

9.92±1.66

12.25±1.39

8.50±1.66

12.97±1.69

589.6±26.10

545.5±24.42

770.9±49.38

638.7±47.20

660.7±42.37

418.4±35.95

337.2±43.59

579.2±42.97

214.6±15.47

196.0±15.11

243.7±29.21

168.0±29.66

186.1±25.59

144.6±21.31

214.0±25.44

275.4±26.87

25.8±1.29

21.3±1.26

19.5±2.42

18.0±2.29

22.1±2.09

17.1±1.89

35.9±2.21

28.9±2.35

LD (RBC/µm)

0.391±0.023

0.317±0.022

0.258±0.044

0.226±0.042

0.285±0.038

0.250±0.032

0.631±0.039

0.477±0.038

VRBCHt(RBCµm/s)

154.2±10.70

126.6±10.45

215.7±19.68

111.2±19.14

145.5±17.37

78.72±15.82

101.4±18.49

190.0±19.14

T (%)
FUNCTIONAL:
VRBC (µm/s)
fRBC (RBC/s)
Ht (%)

τW (N/m2)

0.555±0.034 0.485±0.033 0.647±0.064 0.472±0.061 0.602±0.055 0.309±0.050 0.417±0.059 0.672±0.062
Significant Difference between CN and IR
Data are presented as Mean ± SEM, N= 5 animals, and n = 511 vessels
P<0.01
P<0.05
No Significant Difference between CN and IR
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Table 4-6

The Interactions of Time Post-Irradiation and Radiation Status for Type 2 Vessels
ALL DATA
IRRADIATED
CONTROL

60 DAYS
CONTROL
IRRADIATED

120 DAYS
CONTROL
IRRADIATED

180 DAYS
CONTROL
IRRADIATED

STRUCTURAL:
d (µm)

10.27±0.18

10.12±0.19

9.32±0.29

9.10±0.31

10.57±0.29

10.15±0.35

10.92±0.35

11.10±0.35

L (µm)

249.6±11.51

241.3±11.88

226.3±19.64

262.2±20.89

238.2±18.24

199.4±21.42

284.5±21.80

262.4±19.36

16.16±1.32

16.06±1.36

11.76±2.26

14.32±2.40

17.37±2.10

14.54±2.47

19.35±2.51

19.31±2.23

323.3±17.45

362.4±18.35

432.4±28.96

404.9±31.52

305.5±30.16

255.4±33.09

232.2±31.52

426.8±30.68

58.3±3.62

57.5±3.85

77.5±6.17

51.8±6.56

49.0±5.77

43.7±6.73

48.3±6.85

77.0±6.73

17.7±1.15

17.5±1.23

17.7±1.83

18.3±1.97

14.3±2.01

16.2±2.28

21.1±2.14

18.1±2.14

LD (RBC/µm)

0.219±0.013

0.180±0.013

0.185±0.021

0.159±0.023

0.186±0.022

0.175±0.025

0.285±0.023

0.207±0.023

VRBCHt(RBCµm/s)

68.3±8.07

61.9±8.66

105.6±12.66

70.8±13.69

58.8±13.96

41.56±16.17

40.5±15.20

73.5±15.03

0.259±0.016 0.275±0.017 0.362±0.025
Significant Difference between CN and IR
P<0.01
P<0.05

0.343±0.028

0.212±0.028

0.192±0.031

0.204±0.030

0.29±0.03

T (%)
FUNCTIONAL:
VRBC (µm/s)
fRBC (RBC/s)
Ht (%)

τW (N/m2)

Data are presented as Mean ± SEM, N= 5 animals, and n = 395 vessels
No Significant Difference between CN and IR
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Table 4-7

The Interactions of Time Post-Irradiation and Radiation Status for Type 3 Vessels
ALL DATA
IRRADIATED
CONTROL

60 DAYS
CONTROL
IRRADIATED

120 DAYS
CONTROL
IRRADIATED

180 DAYS
CONTROL
IRRADIATED

STRUCTURAL:
d (µm)

14.39±1.03

17.03±0.89

12.53±1.66

15.66±1.43

15.43±1.70

17.85±1.55

15.21±2.00

17.58±1.66

L (µm)

156.7±11.54

121.3±9.81

125.0±19.19

107.5±16.29

142.4±20.56

109.1±17.57

202.7±20.19

147.3±17.11

12.91±1.59

10.00±1.35

12.32±2.65

9.23±2.25

5.36±2.84

8.15±2.42

21.05±2.79

12.62±2.36

327.2±25.78

389.9±22.02

471.1±42.64

508.1±35.05

269.1±47.67

237.1±40.29

241.3±43.52

424.6±38.92

130.7±26.46

242.2±22.76

168.8±43.44

312.8±36.88

102.3±47.43

173.2±39.76

120.9±46.55

240.5±41.48

34.1±7.46

25.3±6.21

23.6±12.26

28.0±9.54

45.9±12.26

28.5±11.4

32.7±14.16

19.5±11.19

LD (RBC/µm)

0.727±0.149

0.799±0.128

0.540±0.247

0.749±0.203

1.034±0.277

1.044±0.234

0.607±0.277

0.603±0.226

VRBCHt(RBCµm/s)

61.0±8.97

89.3±7.38

93.1±14.74

144.3±10.99

40.34±14.74

53.88±13.75

49.66±17.02

69.9±13.46

0.295±0.033 0.293±0.028 0.416±0.055
Significant Difference between CN and IR
P<0.01
P<0.05

0.443±0.043

0.160±0.055

0.206±0.051

0.310±0.063

0.230±0.050

T (%)
FUNCTIONAL:
VRBC (µm/s)
fRBC (RBC/s)
Ht (%)

τW (N/m2)

Data are presented as Mean ± SEM, N= 5 animals, and n = 205 vessels
No Significant Difference between CN and IR
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Chapter 5. DISCUSSION
Therapeutic doses of ionizing radiation result in changes in the structure and function of
microvascular networks in normal tissue. The late effects of ionizing radiation (60, 120, and 180
days post-irradiation) on microvascular networks were studied in a hamster cremaster muscle
model. The work complemented an earlier study in our lab which examined the early effects of
ionizing radiation (3, 7, and 30 days post-irradiation) on microvascular networks [1-3]. The set
of protocols developed to study the early effects of irradiation was also used to examine the late
effects of ionizing radiation on normal tissue microvascular networks. The early effects study
showed significant changes in the structural and functional parameters of microvascular
networks. Likewise, our late effect study also indicated that ionizing radiation significantly alters
the structure and function of microvascular networks. However, not all parameters that showed
significant changes in the early effects study after irradiation were altered in the late effects
study.
A complete microvascular networks was separated into different vessel types (i.e., type1,
type 2, and type 3) according to the vessel’s bifurcation ends. This method of classification was
more informative than studying randomly selected vessels.

Comparison of Control Data with Literature
As in the early effects study of irradiation, we saw variability in the control data with age
which is due to the normal process of aging. These changes in controls can be attributed to the
normal process of maturation of microvascular networks.

55

Reported studies of microvascular changes with age have not been extended beyond 100
days of age making comparison with other work difficult. In the current study we observed
changes in control animals up to 230 days of age.
In our comparison, only type 2 vessels (one diverging and one converging bifurcation)
will be discussed to compare with “capillary” vessels often reported in literature. In addition, the
comparison below were not made with aged match animals. The average length of “capillaries”
has been reported as 222±7.1 µm [31], while our result indicated type 2 vessel length of 186±6.8
µm. Our early effects study had length of 199±10.7 µm [1]. Average RBC velocity has been
indicated to range from 42 to 545 µm/s with an average of 152 µm/s [32], while our results
suggest RBC velocity in type 2 velocity to be 413.4±15.7 µm/s, and our early effects study had
velocity of 302±14µm/s [1]. Vessel hematocrit has been reported in the range of 1.2 to 32.5%
with an average of 13.3±5.7% [32], while we calculated a vessel hematocrit of 25.9±1.5%.
Vessel diameters were reported to range from 4 to 27 µm for arterioles, capillaries, and venules
[33]. Our studies show vessel diameters to range from 8.42 to 17.7 µm for all vessel types.
Thus, control data from our late effect study are in general agreement with data from our earlier
study and previously published works.

Effects of Irradiation
Consistent with our early effects study, the body weight of irradiated animals was
significantly less than controls at 60 and 120 days post-irradiation. However, at 180 days postirradiation the weight of irradiated animals was not significantly different from controls (see
figure 5-1). In the clinical environment, radiation exposure is known to cause a decrease in body
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weight. Therefore, because the testicle region of hamster comprises 20% of the animal’s body, a
significant drop in body weight at 60 and 120 days post-irradiation seems logical. However, at
180 days post-irradiation, the animal’s weight appears to have recovered from the radiation
exposure. Another possible explanation could be that at 180 days the gain of weight due to aging
is much greater than the late effects of radiation exposure.
Arteriolar tone in irradiated animals was not significantly different from control for all
time post-irradiation. In our early effect study, we saw significant changes only at 3 days post
irradiation and attributed the change to an early response to radiation, possibly affecting the
sensitivity of adenosine receptors [1]. Hence, the current data for the late effects was in
agreement with our earlier study.
Average RBC transit time showed no significant differences between irradiated and
controls. This finding also coincides with our early effects study in which we observed no
significant difference in RBC transit time between irradiated and control animals.
The diameter of irradiated vessels was greater as compared to control for all late time
post-irradiation and significantly greater than controls at 120 days post-irradiation. Data also
suggested that type 3 irradiated vessels were significantly greater than controls for all time postirradiation. We therefore concluded that radiation affected type 3 vessels more than type 1 and
type 2 vessels. The increase in vessel diameter at all time post-irradiation may be due to the
excessive endothelial regeneration in vessel in response to the acute effect of radiation. It has
been documented that immediately after irradiation there is loss of endothelial and smooth
muscle cells [20]. The loss in endothelial and smooth muscle cells can be used to explain the
decrease in vessel diameter due to irradiation that our lab observed in the early effects study. As
the tissue regenerates from the radiation damage, excessive endothelial cells and smooth muscle
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cells regeneration can lead to an increase in vessel diameter [20]. This is consistent with our
findings in both early and late effects studies. As for the latter point, which states that radiation
affects type 3 vessels more than other vessels, the data was in general agreement with our early
effect study [1]. Like our early effects study, this finding could be attributed to normal tissue
maturation and suggests that ionizing radiation alters this maturation process [1].
The tortuosity of vessels was found not to be significantly different between control and
irradiated animals at any time points. However, our early-effect study observed irradiated vessels
to be more tortuous than controls at 7 days post-irradiation. These data differed from published
work, which suggested irradiation leads to ischemic environment that stimulate endothelial
proliferation causing the small veins to become elongated and tortuous [34].
While average RBC velocity decreased with age in control animals, the average RBC
velocity in irradiated vessels showed a decrease from controls at 120 days post-irradiation and
then an increase at 180 days post-irradiation (see figure 4-3). At 120 days post-irradiation only
the RBC velocity in type 1 vessels was significantly smaller as compared to control. Whereas, at
180 days post-irradiation, the increase in velocity from controls was present in all vessel types.
Like our early effect studies, changes in RBC velocity could not be correlated with changes in
vessel diameter.
Significant changes in the RBC flux of irradiated vessels from controls were found only
at 180 days post-irradiation. Here, irradiated animals had higher RBC flux in all vessel types.
Data also showed that type 3 vessels had higher RBC flux in irradiated networks at all time
points. This was in agreement with published work which suggested that loss and occlusion of
capillaries due to irradiation can result in shunting of arterial blood to the venules [35].
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Furthermore, there was no correlation between vessel diameter and RBC flux although both have
similar trends.
The vessel hematocrit of control networks increases over time while the vessel hematocrit
of irradiated networks was unchanged at all time points (see figure 5-4). The vessel hematocrit
of irradiated networks was significantly less than controls at 120 and 180 days post-irradiation.
However, these results differ from our early time points that found a significant increase in vessel
hematocrit of irradiated network at both 7 and 30 days post-irradiation.
At 60 and 120 days post-irradiation, vessel wall shear stress in type 1 irradiated vessels
was significantly smaller than controls while at 180 days post-irradiation, vessel wall shear stress
in type 1 irradiated vessels was significantly greater than controls. Vessel wall shear stress has
been shown to cause changes in the rolling and adhering of leukocytes in venules. However, our
data found significant changes in only type 1 vessels and not type 3 suggesting that rolling and
adhering of leukocytes may not be significantly affected. This contradicts published work and
thus more research needs to be perform in this area. In addition, it has been hypothesized that
microvascular network remodeling is regulated by mechanical stress (i.e., vessel wall shear
stress) [36]. In particular, changes in vessel diameter are often correlated with changes in vessel
shear stress (see Equation 4-15). However, in the current study, we did not observe a correlation
between vessel diameter and wall shear stress. Therefore, vessel wall shear stress may not play
an important role in remodeling after irradiation since data showed not difference from controls.
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Chapter 6. CONCLUSION
1) Therapeutic doses of ionizing radiation significantly alter the structure and function of
normal tissue microvascular networks at 60, 120, and 180 days post-irradiation.
2) Studying complete microvascular networks is more informative than just randomly selected
vessels.
3) Therapeutic doses of ionizing radiation interfere with the normal maturation process of the
microvascular networks.
4) Type 3 vessels (post capillary venules) are the most sensitive to radiation.

The early effects and late effects studies have set a foundation for our study of how ionizing
radiation affects normal tissue. We hope to continue the study by using the collected data to
mathematically model the oxgenation of microvascular networks. We believe ionizing radiation
might alter the oxygen delivery to the tissue. In addition, Prabhakar Pandian has begun to
examine how ionizing radiation affects human endothelial cells, and Hong Yuan has begun to
observe how ionizing radiation affects the blood brain barrier.
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Appendix A
Steps In Tracing a Network and Creating Topology
1) Configuring drawing screen
Configure Calcomp DrawingBoard III to make sure the board drawing area fits on
Autocad screen. If not, go under “Options” and then to “Tablet” and “Configure”. Follow
instructions.
2) Digitize setup
Under “Map”, go to “Data entry”, then “Digitize setup.” Check “Linear” in Object Type
box. The pre-setting should be Create on Layer= “0”, Linetype= “Bylayer”, Elevation=
“2D”, and Width= “0.00”. Click “OK” if setting is correct.
3) Digitize Network
Under “Map”, go to “Data entry”, then “Digitize.” Start tracing network using the
Calcomp Digital Mouse which has 4 buttons numbered 0-3. Make sure to start at the feeding
vessels and work your way down the network. Click the “0” button at every curvature for
each vessel. Each time the “0” button is press will represent a blue grip in AutoCAD
drawing. Once a vessel is drawn press the 1 button to begin a new vessel. Before pressing
the 0 button to start a new vessel, press the “2” button, and select “endpoint” if you are
beginning a new bifurcation or select “intersection” if you are finishing a bifurcation. This
will cause the end grips of the vessels to overlap at nodes, thus connecting vessels together.
When done, zoom in the drawing to make sure that all the end grips are connected at each
bifurcation. This is very important because topology will not work, otherwise. To perform
this task, zoom in and click on three vessels so that blue grips will appear. When all three
vessels are connected, moving the common grip will cause animation in the three vessels.
Lastly, using an image of a micrometer, draw a line 100 um near the network.
4) Create Topology Query
Under “Map”, go to “Topology” and then to “Create.” In the Define Topology box, name
the topology as “Connections” and gives its description as “Vessel Connections”. Select the
type of topology as “Network”. Under Topology Objects, select “Node Objects”, and when
an Node Object Box opens, select “Select Automatically” and “Create Node Objects”. Click
OK. Also under Topology Objects, select “Link Objects” and then select “Select
Automatically.” Click OK. Lastly, click “Proceed”. If the topology was created successful,
at the command prompt, it should read “topology successfully created” and the number of
objects created.
5) Define Topology Query to Draw
Under “Map”, go to “Define Topology Query”. Under Name Query Topology, the
default should read “Connections”. Otherwise, select “Load” and another box will open
which will allow you to select “Connections”. After “Connections” has been set as the
Topology Name, select “Define Query.” A Define Query box should open. In the Query
Type section, select “AND”,and then select “Property.” After the Property Condition box
opens, select “Object Type” and then “Value.” After Select box opens, select
“2DPOLYLINE” and then OK. Click OK again to close the Property Condition box. (This
query only find 2Dpolylines, but since the lastest version of AutoCAD 14 save the lines as
lightweight polylines, another query must be performed.) Next, in the Query Type section,
66

select “OR” and then “Property”. Again, select “Object Type” and then “Value”. In the
Select box, scroll down and select “LWPOLYLINE”. Click OK and then OK again to get
back to the Define Query box. In the Query Mode section, select “Draw”, and in the Options
section, select “Alter Properties..”. Once the Set Alteration Properties box appears, select
“Text”. A Define Text box will appear. Select “Data” and a Select Data box will appear. In
“Tables:”, scroll down and select the “TPMLINK Connections”. This will allow you to
select “ID” as the first Data Field. Click OK. The ID address is now in the “Text Value”
section. Select “Color Palette” so you can change the color to blue. Perform the above
procedure again to get “Start Node” and “End Node”. The Node’s heights is 0.15 and colors
are red and magenta, repectively. After getting back to the Define Query box, select
“Execute Query”, and three seconds later the IDs and Nodes will be display on each vessels.
6) Editing Text Values
After text values have been generated , move ID values to their corresponding vessels.
Node should be placed at start and end of vessels. Some start and end nodes will need to be
deleted because nodes will overlap at bifurcation.
7) Define Topology Query to Report
Like above, set query type to “2DPOLYLINES” or “LWPOLYLINE”. In the Query
Mode, select “Report” and click on “Options”. An Output Report Option box will appear.
Select “Data”, and then again choosing TPMLINK Connections table, select ID. Click OK
and then select “Add” to add the address to the report template. Again do the same for Start
and End Nodes. Next select “Properties” and scroll down and select “length”. Click OK and
select “Add” to add to report template. Perform this task again for object start point and
object end point. Lastly, select “Browse in the Output Report Option” and select the name
and directory of the text file. Click OK, and select “Execute Query.” Using Windows
Explorer, check the output file.

How to Run Colwid.lsp to Change Diameter and Color of Vessels
1) Format of External Database
Create an excel file with two columns. The first column contains normalized diameter
values which can be real numbers, and the second column contains the color code which
must be integer ranging from 0 to 256. The order of the values in the columns must start
with the smallest ID number and go down to highest. The excel file must then be save as a
text file in a specific directory that matches with the name of text file in the program.
2) Changing the name and location of the database in Colwid.lsp
Open Colwid.lsp in Notepad. The second line of text reads
(setq f (open "e:\\vinh\\test\\test2.txt" "r"))
This means that the current location of the database is stored in “e:\vinh\test\test2.txt”. If the
file is saved elsewhere, only change the content of the first quotation. For example, if the file
is now called “d:\program files\autocad\diamcolor.txt”, then the second line in Colwid.lsp
should read as
(setq f (open "e:\\progam files\\autocad\\diamcolor.txt" "r"))
Afterward, save the file as Colwid.lsp.
3) Executing the Routine
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Open the desire AutoCAD drawing. Zoom the drawing to “Extent” so that every object
fits in the drawing screen. Turn on only the layer that contain the polylines of vessels. At the
command prompt, type “appload”. After a Load AutoLisp File box appears, select “File” to find
colwid.lsp and then select “Load”. The file is now loaded, type “colwid” at the command prompt
to execute the program. The diameter and color of vessels should change instantly.

Body of Text for Colwid.lsp
(defun c:colwid()
(setq f (open "e:\\vinh\\test\\test2.txt" "r"))
(setq ss1 (ssget "X" '((0 . "LWPOLYLINE"))))
(setq n (sslength ss1))
(setq test 1)
(while (>= n test)
(princ test)
(setq d (read-line f))
(setq g (read d))
(setq x (- test 1))
(setq en (ssname ss1 x))
(setq ed (entget en))
(setq ed
(subst (cons 43 g) (assoc 43 ed) ed))
(entmod ed)
(setq test (+ test 1))
)
(close f)
(setq f (open "e:\\vinh\\test\\test2.txt" "r"))
(setq test 1)
(while (>= n test)
(princ test)
(setq first 100)
(while (/= first 10)
(setq a (read-char f))
(if (= a 9)
(progn
(princ test)
(setq b (read-char f))
(setq c (read-char f))
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(if (and (/= c 10) (/= c nil))
(progn
(setq d (read-char f))
(princ test)
(if (/= d 10)
(progn
(setq e (read-char f))
(setq x 3)
(setq first 10)
(setq k (atoi (chr b)))
(setq h (atoi (chr c)))
(setq i (atoi (chr d)))
(setq g (+ (* k 100) (+ (* h 10) i)))
)
)
(if (= d 10)
(progn
(setq first 10)
(setq k (atoi (chr b)))
(setq h (atoi (chr c)))
(setq g (+ (* k 10) h))
)
)
)
)
(if (= c 10)
(progn
(setq first 10)
(setq g (atoi (chr b)))
)
)
)
)
)
(setq x (- test 1))
(setq en (ssname ss1 x))
(setq ed (entget en))
(setq ed
(subst (cons 62 g) (assoc 62 ed) ed))
(entmod ed)
(setq test (+ test 1))
)
(close f)
)
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Appendix B
Summary of Data for Early And Late Effects Studies.
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Figure B-1. Animal weight at 3, 7, 30, 60, 120, 180 days post-irradiation
(N=5 animals per time point per treatment group. Data are presented as
Mean ± SEM (P<0.05).
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RBC Velocity (µm/s)
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Figure B-2. RBC velocity at 3, 7, 30, 60, 120, 180 days postirradiation (N=5 animals per time point per treatment group).
Data are presented Mean ± SEM (P<0.05).
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Figure B-3. Vessel hematocrit at 3, 7, 30, 60, 120, 180 days postirradiation (N=5 animals per time point per treatment group). Data
are presented Mean ± SEM (P<0.05).
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